| Detected | Trial | Change |
|---|---|---|
| 2026-08-14 | NCT07223723 A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese… |
Enrollment closed, study ongoing |
| 2026-08-14 | NCT07223723 A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese… |
date change Primary completion moved earlier: 2027-12-16 -> 2027-05-26 |
| 2026-08-14 | NCT07223723 A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese… |
date change Completion moved earlier: 2027-12-16 -> 2027-05-26 |
| 2026-08-14 | NCT05352919 An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059)… |
Trial sites expanded: 197 -> 203 locations |
| 2026-08-12 | NCT07722546 A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in… |
Recruitment opened |
| 2026-08-12 | NCT07722546 A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in… |
Trial sites expanded: 0 -> 3 locations |
| 2026-08-12 | NCT04729907 A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given… |
Trial completed |
| 2026-08-12 | NCT07444450 A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to… |
Recruitment opened |
| 2026-08-11 | NCT06962800 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults… |
date change Primary completion pushed: 2028-12-29 -> 2030-01-28 |
| 2026-08-11 | NCT06962800 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults… |
date change Completion pushed: 2029-03-29 -> 2031-01-17 |
| 2026-08-08 | NCT06854042 A Study of Oral E1018 in Healthy Adult Participants |
Enrollment closed, study ongoing |
| 2026-08-08 | NCT06854042 A Study of Oral E1018 in Healthy Adult Participants |
date change Primary completion pushed: 2025-12-23 -> 2027-07-22 |
| 2026-08-08 | NCT06854042 A Study of Oral E1018 in Healthy Adult Participants |
date change Completion pushed: 2025-12-23 -> 2027-07-22 |
| 2026-08-07 | NCT07444489 A Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in… |
Trial sites expanded: 2 -> 8 locations |
| 2026-08-06 | NCT06935357 A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin… |
Trial sites expanded: 251 -> 256 locations |
| 2026-07-28 | NCT07662148 A Study to Learn More About the Safety of a Single Dose of BIIB144 and How it is… |
Recruitment opened |
| 2026-07-23 | NCT06935357 A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin… |
Trial sites expanded: 248 -> 251 locations |
| 2026-07-19 | NCT06064929 A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus… |
Trial completed |
| 2026-07-19 | NCT04572295 A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in… |
Trial completed |
| 2026-07-19 | NCT04572295 A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in… |
date change Primary completion moved earlier: 2027-03-31 -> 2026-06-18 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-14 | NCT07766369 A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy Participants | Phase 1 | Not Yet Recruiting |
| 2026-08-13 | NCT07762092 A Post Authorization Registry Study of Participants Treated With LEQEMBI | Not Yet Recruiting | |
| 2026-07-23 | NCT07722546 A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in… | Phase 2 | Recruiting |
| 2026-07-23 | NCT07723950 A Retrospective Database Study for the Development and Validation of Algorithms for… | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06964113 | A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active… | Ulcerative Colitis | Active, Not Recruiting |
| NCT07223723 | A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese… | Amyotrophic Lateral Sclerosis | Active, Not Recruiting |
| Phase 3 | |||
| NCT07444476 | A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in… | Spinal Muscular Atrophy | Recruiting |
| NCT06953583 | A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141)… | Friedreich Ataxia | Recruiting |
| NCT06935357 | A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin… | Immunoglobulin A Nephropathy (IgAN) | Recruiting |
| NCT06962800 | A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults… | Primary Membranous Nephropathy | Recruiting |
| NCT07221669 | A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When… | Muscular Atrophy, Spinal | Recruiting |
| NCT07444450 | A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to… | Muscular Atrophy, Spinal | Recruiting |
| NCT03958877 | A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon… | Multiple Sclerosis, Relapsing-Remitting | Active, Not Recruiting |
| NCT04961567 | A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They… | Lupus Erythematosus, Systemic | Active, Not Recruiting |
| NCT04895241 | A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They… | Lupus Erythematosus, Systemic | Active, Not Recruiting |
| NCT02811861 | Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of… | Renal Cell Carcinoma | Active, Not Recruiting |
| NCT07483632 | A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF)… | Relapsing Forms of Multiple Sclerosis | Not Yet Recruiting |
| NCT04856982 | A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a… | Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation | Active, Not Recruiting |
| NCT03887455 | A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early… | Early Alzheimer's Disease | Active, Not Recruiting |
| NCT05067790 | A Study to Learn About the Effect of Higher Doses of Nusinersen (BIIB058) Given as… | Spinal Muscular Atrophy | Active, Not Recruiting |
| NCT04468659 | AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in… | Preclinical Alzheimer's Disease | Active, Not Recruiting |
| NCT06685757 | A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults… | Antibody-mediated Rejection | Active, Not Recruiting |
| NCT06044337 | A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059)… | Subacute Cutaneous Lupus Erythematosus | Enrolling by Invitation |
| NCT07444489 | A Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in… | Antibody-mediated Rejection | Enrolling by Invitation |
| NCT05352919 | An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059)… | Systemic Lupus Erythematosus (SLE) | Enrolling by Invitation |
| Phase 2/3 | |||
| NCT05531565 | A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of… | Subacute Cutaneous Lupus Erythematosus | Active, Not Recruiting |
| Phase 2 | |||
| NCT07493265 | A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy | Narcolepsy | Recruiting |
| NCT07515014 | A Study of E6742 in Participants With Systemic Lupus Erythematosus | Systemic Lupus Erythematosus | Recruiting |
| NCT07219043 | A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney… | Microvascular Inflammation | Recruiting |